Kynurenic Acid (KYNA)
Kinurenic acid; Kynuronic acid; Kuinurenic acid; Transtorine
-93718.jpg)
KYNA) is a product of the normal metabolism of amino acid L-tryptophan. It has been shown that kynurenic acid possesses neuroactive activity. It acts as an antiexcitotoxic and anticonvulsant, most likely through acting as an antagonist at excitatory amino acid receptors. Because of this activity, it may influence important neurophysiologic and neuropathologic processes. As a result, kynurenic acid has been considered for use in therapy in certain neurobiological disorders. Conversely, increased levels of kynurenic acid have also been linked to certain pathological conditions.
Kynurenic acid was discovered in 1853 by the German chemist Justus von Liebig in dog urine. It is formed from L-kynurenine in a reaction catalyzed by the enzyme kynurenine—oxoglutarate transaminase.
Organism species: Pan-species (General)
- Conjugated small molecules CPD718Ge11 BSA Conjugated Kynurenic Acid (KYNA) In Stock
- Conjugated small molecules CPD718Ge21 OVA Conjugated Kynurenic Acid (KYNA) In Stock
- Polyclonal antibody PAD718Ge01 Polyclonal Antibody to Kynurenic Acid (KYNA) In Stock
- Competition ELISA CED718Ge ELISA Kit for Kynurenic Acid (KYNA) In Stock